An Investigation Has Commenced on Behalf of Novavax, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your NVAX Losses
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Novavax, Inc. for potential violations of federal securities laws. This follows the FDA's clinical hold on Novavax's combination influenza and Covid-19 shot and its stand-alone influenza vaccine.
November 08, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Novavax is under investigation for potential securities law violations after the FDA placed a clinical hold on its vaccine developments.
The investigation by Levi & Korsinsky and the FDA's clinical hold on Novavax's vaccine developments are likely to negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100